Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.
The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology. 2009 Dec 15; 73(24):2058-9.
View in:
PubMed
subject areas
Brain Ischemia
Coronary Artery Bypass
Cytoprotection
Enzyme Inhibitors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Preoperative Care
Stroke
authors with profiles
Larry Goldstein